Diphtheria
Diphtheria is a bacterial infection that mainly affects the throat and nose. It is preventable with vaccination, but it still causes outbreaks where routine immunization is weak or disrupted. WHO says it spreads from person to person through close physical contact and through the air via respiratory droplets. In severe cases, the bacteria make a toxin, a poison that can form a thick grey or white coating in the throat and damage the heart, nerves, and kidneys. WHO reports that diphtheria is fatal in about 5% to 10% of cases overall, with higher death rates in young children and in places with poor access to diphtheria antitoxin. Treatment is urgent and usually includes diphtheria antitoxin plus antibiotics. Vaccines work well, but outbreaks can still happen when many people have missed doses or boosters. Recent WHO notices show continuing transmission in parts of Africa and earlier outbreaks in Asia and the Middle East, especially in crowded or fragile settings.
Key facts
| Transmission | Person to person through close physical contact and respiratory droplets; also caused mainly by toxigenic Corynebacterium diphtheriae and sometimes C. ulcerans. |
|---|---|
| Incubation | unknown |
| Case fatality | WHO: usually 5% to 10% of cases; in settings with poor access to diphtheria antitoxin, up to 40%. In Guinea in 2023, CFR among all reported cases was 11%; in the WHO African Region in 2025, average CFR among suspected cases was about 6%. |
| Reproduction number | unknown |
| Vaccine | Yes. Diphtheria toxoid-containing vaccines are available and WHO describes diphtheria as vaccine-preventable. |
| Treatment | Diphtheria antitoxin plus antibiotics; WHO outbreak pages mention antibiotics such as amoxicillin and azithromycin in Guinea and note global shortages of diphtheria antitoxin. |
| Reservoir | Humans are the main reservoir for Corynebacterium diphtheriae; WHO also notes some diphtheria is caused by Corynebacterium ulcerans. |
| Endemic regions | Unknown as a fixed list. Recent WHO notices show outbreaks in several African countries, and earlier WHO notices reported outbreaks in Bangladesh, Yemen, Afghanistan, Laos, and Thailand. |
Transmission
WHO describes diphtheria as a highly contagious disease spread mainly from person to person through close physical contact and through the air in respiratory droplets. That means it can pass during face-to-face contact, especially in households, schools, clinics, shelters, or other crowded places. WHO also notes that the main cause is toxin-producing Corynebacterium diphtheriae, although some cases are linked to Corynebacterium ulcerans. Outbreak reports from Guinea and the wider African Region show that transmission is easier where vaccination coverage is low, laboratories are limited, and case finding is slow. The 2025 WHO regional notice also highlights high population movement and crowded living conditions, especially among displaced people, as conditions that help outbreaks grow. A basic but important point for readers is that diphtheria is preventable: strong routine vaccination and quick response to suspected cases are central to stopping spread.
- Diphtheria-Guinea WHO · 18 Oct 2023
- Diphtheria - African Region (AFRO) WHO · 21 Nov 2025
Symptoms and severity
Diphtheria often starts gradually with a sore throat and fever. WHO says severe illness can produce a thick grey or white patch at the back of the throat that can make breathing or swallowing hard. Some patients develop a barking cough or a swollen neck. The disease can also become dangerous because the bacterial toxin may damage other organs. WHO’s 2025 African regional notice lists serious complications including myocarditis, which is inflammation of the heart, kidney failure, and neurological damage. Severity varies a lot. WHO states diphtheria is fatal in about 5% to 10% of cases overall, with higher mortality in young children. In places where diphtheria antitoxin is hard to get, WHO says the case fatality ratio can reach 40%. Recent outbreak reports show how much outcomes depend on access to diagnosis and care: Guinea reported an 11% fatality ratio among all reported cases in 2023.
- Diphtheria-Guinea WHO · 18 Oct 2023
- Diphtheria - African Region (AFRO) WHO · 21 Nov 2025
Treatment and vaccines
Diphtheria needs prompt treatment. WHO says treatment involves diphtheria antitoxin, often shortened to DAT, together with antibiotics. The antitoxin is used to neutralize circulating toxin, while antibiotics help clear the bacteria and reduce onward spread. In the Guinea outbreak, WHO reported first-line therapy with amoxicillin and azithromycin and also described antibiotic prophylaxis for close contacts. Vaccination is the main protection. WHO repeatedly calls diphtheria a vaccine-preventable disease and says vaccination dramatically reduces illness and death. The practical problem in current outbreaks is not that vaccines do not exist, but that many people have missed routine doses or boosters. WHO also warns of a global shortage of diphtheria antitoxin, which makes severe cases harder to manage. For readers, the key message is simple: prevention depends on keeping vaccination coverage high, and survival improves when suspected cases are recognized and treated early.
- Diphtheria-Guinea WHO · 18 Oct 2023
- Diphtheria-Nigeria WHO · 13 Sept 2023
- Diphtheria - African Region (AFRO) WHO · 21 Nov 2025
- Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Europe PMC · 27 Apr 2018
Where it occurs
Diphtheria is not confined to one country, but recent WHO notices show it is now a particular concern in places where routine immunization has gaps or has been disrupted by conflict, displacement, or weak health services. WHO’s 2025 regional report describes large ongoing outbreaks across eight countries in the African Region: Algeria, Chad, Guinea, Mali, Mauritania, Niger, Nigeria, and South Africa. Several of those outbreaks have continued since 2023. Earlier WHO Disease Outbreak News items in the archive show outbreaks in Yemen and among displaced Rohingya people in Cox’s Bazar, Bangladesh, in 2017, in Afghanistan in 2003, and in Laos and Thailand in 1996. The pattern is consistent: outbreaks tend to appear where many children and young adults are unvaccinated or under-vaccinated, and where crowded living conditions make transmission easier. WHO considers the regional risk in Africa high, but says the global risk is low because many countries have stronger immunization and surveillance systems.
- Diphtheria - African Region (AFRO) WHO · 21 Nov 2025
- Diphtheria – Yemen WHO · 22 Dec 2017
- Diphtheria – Cox’s Bazar in Bangladesh WHO · 13 Dec 2017
- Diphtheria in Afghanistan WHO · 29 Aug 2003
Recent history
This site’s archive count is 7 WHO-linked diphtheria events since 1996, which shows that diphtheria is not new but has returned repeatedly in periods of low vaccination coverage or humanitarian stress. The older archive items are Laos and Thailand in 1996, Afghanistan in 2003, and major notices from Bangladesh and Yemen in 2017. WHO then reported a renewed rise in Nigeria in 2023, with one notice in April and another in September describing an unusual increase across several states. Guinea also reported an outbreak in 2023, centered in Kankan region, with 538 reported cases and 58 deaths by 2023-10-13. The most recent WHO regional notice, published on 2025-11-21, describes a much broader African resurgence: 20,412 suspected cases and 1,252 deaths across eight countries from 2025-01-01 to 2025-11-02. WHO says several of these countries have had ongoing outbreaks since 2023, and it graded the regional situation as a serious public health concern.
- 1996 - Diphtheria in Laos and Thailand WHO · 19 Jul 1996
- Diphtheria in Afghanistan WHO · 29 Aug 2003
- Diphtheria – Cox’s Bazar in Bangladesh WHO · 13 Dec 2017
- Diphtheria – Yemen WHO · 22 Dec 2017
What to watch
The signs that would make diphtheria more concerning are clear from WHO’s recent reports. First is spread into new regions or more countries, especially if outbreaks move beyond current hotspots in the African Region. Second is evidence of sustained transmission in crowded settings such as displacement camps, schools, or areas with high population movement. Third is a rise in severe outcomes: more deaths, more cases with heart, nerve, or kidney complications, or case fatality ratios climbing because care is delayed. Fourth is strain on treatment capacity. WHO specifically warns that the global shortage of diphtheria antitoxin is already hampering response, so supply problems would make future outbreaks harder to control. Fifth is any widening immunity gap, such as many cases in older children, teenagers, or adults, which WHO has already observed in the African outbreaks. Finally, watch vaccination coverage and laboratory confirmation. Low coverage, weak testing, and delayed case recognition are the main conditions that let diphtheria keep spreading.
- Diphtheria - African Region (AFRO) WHO · 21 Nov 2025
- Diphtheria-Guinea WHO · 18 Oct 2023
- Diphtheria – Cox’s Bazar in Bangladesh WHO · 13 Dec 2017